Prosecution Insights
Last updated: April 19, 2026

Actelion Pharmaceuticals Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18547959 METHODS FOR TREATING PULMONARY HYPERTENSION IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION DAHLIN, HEATHER RAQUEL 1629 Non-Final OA Aug 25, 2023
18262777 PROCESS FOR MANUFACTURING A DIPHENYLPHRAZINE DERIVATIVE VAJDA, KRISTIN ANN 1622 Non-Final OA Jul 25, 2023
18258675 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS STOCKTON, LAURA LYNNE 1626 Non-Final OA Jun 21, 2023
17616313 METHODS FOR TREATING PULMONARY ARTERIAL HYPERTENSION LEE, WILLIAM Y 1623 Final Rejection Dec 03, 2021

Managing Actelion Pharmaceuticals Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month